Aytu BioPharma, Inc. Common Stock (AYTU)

Typically moves ±13.65% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-09-11 ESTIMATED

Aytu BioPharma, Inc. Common Stock (AYTU) has a 22-report earnings history dating back to May 17, 2021. Its average absolute post-earnings move is ±13.65%, and 27.3% of those reactions were positive. Its largest post-earnings gain was +84.78% (May 14, 2025) and its largest decline was -22.11% (May 11, 2023). The next earnings report is predicted for 2026-09-11 (estimated).

Earnings reactions

How AYTU moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±13.65%

Positive %

27.3%

Negative %

72.7%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 13, 2026	☽ POST	-1.53%	open_in_new
Apr 02, 2026	☽ POST	-2.55%	open_in_new
Feb 03, 2026	☽ POST	-14.23%	open_in_new
Nov 13, 2025	☽ POST	+3.77%	open_in_new
Sep 23, 2025	☽ POST	-18.9%	open_in_new
May 14, 2025	☽ POST	+84.78%	open_in_new
Feb 12, 2025	☽ POST	+0%	open_in_new
Nov 13, 2024	☽ POST	-15.53%	open_in_new
Sep 26, 2024	☽ POST	-7.48%	open_in_new
May 15, 2024	☽ POST	-11.56%	open_in_new
Feb 14, 2024	☽ POST	-0.32%	open_in_new
Nov 14, 2023	☽ POST	-17.65%	open_in_new
Sep 27, 2023	☽ POST	+47.83%	open_in_new
May 11, 2023	☽ POST	-22.11%	open_in_new
Feb 21, 2023	☽ POST	-4.5%	open_in_new
Nov 14, 2022	☽ POST	-7.27%	open_in_new
Sep 28, 2022	☽ POST	-1.63%	open_in_new
May 16, 2022	☽ POST	+12.89%	open_in_new
Feb 14, 2022	☽ POST	+3.88%	open_in_new
Nov 15, 2021	☽ POST	-9.67%	open_in_new
Sep 27, 2021	☽ POST	-9.18%	open_in_new
May 17, 2021	☽ POST	-3.04%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±13.65%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 8 →

Funds holding

$116141

Total value held

Buying

4 added · 0 reduced

Northern Trust Corp

$60039 +45.68%

Blackrock, Inc.

$49005 Held

Ubs Group Ag

$5110 NEW BUY

Royal Bank Of Canada

$1000 +950.00%

Jpmorgan Chase & Co

$337 Held

SEC Filing Types

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
4	20260730	open_in_new SEC.gov
4	20260730	open_in_new SEC.gov
4	20260730	open_in_new SEC.gov
4	20260730	open_in_new SEC.gov
4	20260730	open_in_new SEC.gov
4	20260730	open_in_new SEC.gov
4	20260730	open_in_new SEC.gov
4	20260730	open_in_new SEC.gov
8-K	20260625	open_in_new SEC.gov

Frequently asked about AYTU earnings

When does Aytu BioPharma, Inc. Common Stock report earnings next? expand_more

Aytu BioPharma, Inc. Common Stock (AYTU)'s next earnings date is estimated for 2026-09-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does AYTU stock move after earnings? expand_more

Over 22 reports, AYTU has moved an average of ±13.65% the session after earnings, closing higher 27.3% of the time.

What was AYTU's biggest post-earnings move? expand_more

AYTU's largest post-earnings gain on record was +84.78% on May 14, 2025, and its largest decline was -22.11% on May 11, 2023.

Where can I find Aytu BioPharma, Inc. Common Stock's SEC filings? expand_more

All of Aytu BioPharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.